Physician profile
Matthew Tobin
NPI 1306475116
$7,168.13
in general payments reported to CMS, 2019-2025
6 companies · $2,874 in 2025
The $2,874 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $207 · 2023: $270 · 2024: $3,817 · 2025: $2,874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,585 · Food and Beverage: $2,116 · Education: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,585.28 |
| Food and Beverage | $2,115.53 |
| Education | $260.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,686.93 | 2022-2025 | Surpass Evolve, Neuroform Ez 3, Target |
| Medtronic, INC. | $2,097.90 | 2022-2024 | Pipeline, Mazor X System, Cd Horizon Spinal System |
| Microvention, INC. | $165.97 | 2025 | Stent, Web Aneurysm Embolization System, Sofia 6f-131cm Str |
| Penumbra, INC. | $106.50 | 2025 | Red 72 |
| Imperative Care, INC | $91.54 | 2024-2025 | Zoom 88-T Large Distal Platform |
| Depuy Synthes Sales INC. | $19.29 | 2024 | Synthecel, Matrixneuro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Tobin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.